Hepatitis B surface antigen (HBsAg) prevalence in North Macedonia
North Macedonia: Hepatitis B surface antigen (HBsAg) prevalence was 0.2% in 2024. ▲ Rising
Latest (2024)
0.2%
Change on year
up 100.0%
World rank
82nd
of 194 countries
All-time high
0.2%
in 2024
All-time low
0.1%
in 2015
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in North Macedonia, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in North Macedonia is 0.2%, measured in 2024. That is the highest value across all 10 years on record.
The figure is up 100.0% on the previous year and up 100.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in North Macedonia peaked at 0.2% in 2024 and was at its lowest, 0.1%, in 2015.
That places North Macedonia 82nd out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in North Macedonia, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.1% | +0.0% |
| 2017 | 0.1% | +0.0% |
| 2018 | 0.1% | +0.0% |
| 2019 | 0.1% | +0.0% |
| 2020 | 0.1% | +0.0% |
| 2021 | 0.1% | +0.0% |
| 2022 | 0.1% | +0.0% |
| 2023 | 0.1% | +0.0% |
| 2024 | 0.2% | +100.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.1% | 5 |
| 2020s | 0.1% | 0.1% | 0.2% | 5 |
Countries ranked near North Macedonia
- 82 Tajikistan 0.2% compare
- 82 Saint Vincent and the Grenadines 0.2% compare
- 82 Venezuela, Bolivarian Republic of 0.2% compare
- 82 Antigua and Barbuda 0.2% compare
- 82 Bahamas 0.2% compare
- 82 Barbados 0.2% compare
- 82 Dominica 0.2% compare
- 82 Fiji 0.2% compare
- 82 Grenada 0.2% compare
- 82 India 0.2% compare
- 82 Jamaica 0.2% compare
- 82 Kazakhstan 0.2% compare
- 82 Saint Kitts and Nevis 0.2% compare
- 82 Libya 0.2% compare
- 82 Saint Lucia 0.2% compare
- 82 Maldives 0.2% compare
- 82 Nepal 0.2% compare
- 82 Pakistan 0.2% compare
More health data for North Macedonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0 % change on previous year (2090)
- Heat deaths vs projected death rates 1,700 (2090)
- Un projection of annual infant deaths 8 (2100)
- Population ages 0-14, female, annual growth rate -2.09 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0805 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.78 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0848 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in North Macedonia?
- Hepatitis b surface antigen (hbsag) prevalence in North Macedonia was 0.2% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in North Macedonia?
- The highest recorded value was 0.2% in 2024.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in North Macedonia?
- The lowest recorded value was 0.1% in 2015.
- How does North Macedonia rank for hepatitis b surface antigen (hbsag) prevalence?
- North Macedonia ranks 82nd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in North Macedonia?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is rising.
- Where does this North Macedonia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).